Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00492622 · ClinicalTrials.gov registry record · Phase 4
Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis
A Phase 4 study, sponsored by University of Louisville.
- Completed
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
NCT00492622 is a Phase 4 study that has completed, run by University of Louisville. The registered enrollment target is 12 participants.
The verdict
NCT00492622, a Phase 4 study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the blood drug levels of two prescribed medications, immediate-release omeprazole 40 mg powder and delayed-release omeprazole 40 mg capsule to determine which drug is better absorbed in patients with a slow stomach emptying (gastroparesis). Delayed-release omeprazole has a protective coating to prevent the drug omeprazole from being neutralized by stomach acid. Immediate-release omeprazole has sodium bicarbonate (antacid) which neutralizes the stomach acid, eliminating the need for a protective coating. Immediate-release omeprazole suspension may have a more rapid pharmacokinetic profile and greater overall drug absorption in gastroparesis.
Interventions
- DRUG Immediate-release omeprazole
- DRUG Delayed-release omeprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2007-06 |
| Est. Completion | 2008-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00492622
The ClinicalTrials.gov registry entry for NCT00492622 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Immediate-release omeprazole is the first listed.
NCT00492622 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00492622 about?
NCT00492622 is a clinical study titled "Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis". The purpose of this study is to compare the blood drug levels of two prescribed medications, immediate-release omeprazole 40 mg powder and delayed-release omeprazole 40 mg capsule to determine which drug is better absorbed in patients with a slow stomach emptying (gastroparesis). Delayed-release ome...
What is the current status of trial NCT00492622?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2007-06. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00492622?
The interventions under investigation include: Immediate-release omeprazole (DRUG), Delayed-release omeprazole (DRUG).
Who is sponsoring clinical trial NCT00492622?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.